Only 14 of the 477 radiation oncology facilities accredited by the American Society for Radiation Oncology hold its radiopharmaceutical therapy designation.
The designation is part of ASTRO’s Accreditation Program for Excellence, or APEx, which assesses whether radiation oncology practices meet the society’s quality and safety standards.
The radiopharmaceutical therapy review is a separate accreditation specific to radioactive drug therapies, according to ASTRO.
Here are the 14 facilities with ASTRO’s radiopharmaceutical therapy accreditation, in alphabetical order:
- Baptist MD Anderson Cancer Center (Jacksonville, Fla.)
- Baptist MD Anderson Cancer Center at Baptist South (Jacksonville, Fla.)
- City of Hope Radiation Oncology (Duarte, Calif.)
- Community Health Network MD Anderson Cancer Center East (Indianapolis)
- Miami Cancer Institute at Baptist Health South Florida (Miami)
- Miami Cancer Institute at Plantation (Fla.)
- Northeast Radiation Oncology Center (Dunmore, Pa.)
- Portneuf Cancer Care (Pocatello, Idaho)
- Radiotherapy Centers of Kentuckiana (Jeffersonville, Ind.)
- RWJBarnabas Health Cooperman Barnabas Medical Center (Livingston, N.J.)
- RWJBarnabas Health Robert Wood Johnson University Hospital (New Brunswick, N.J.)
- Siteman Cancer Center at Barnes-Jewish Hospital (St. Louis)
- Siteman Cancer Center at Memorial Hospital East (Shiloh, Ill.)
- St. Francis Radiation Oncology (East Hills, N.Y.)
At the Becker's Perioperative Summit, taking place September 14–15 in Chicago, perioperative leaders and healthcare executives will focus on improving operating room efficiency, enhancing patient safety, optimizing staffing and driving innovation across surgical services. Apply for complimentary registration now.
